XML 44 R34.htm IDEA: XBRL DOCUMENT v3.22.1
Business Combination (Tables)
3 Months Ended
Mar. 31, 2022
Business Acquisition [Line Items]  
Reconciles the Elements of Business Combination to Consolidated Statements
The following table reconciles the elements of the Business Combination to the consolidated statement of cash flows and the consolidated statement of changes in equity for the three months ended March 31, 2021:

 (Amounts in thousands)
 
Recapitalization
 
Cash- AMCI’s trust and cash (net of redemptions)
 
$
93,311
 
Cash – PIPE plus interest
   
65,000
 
Less transaction costs and advisory fees paid
   
(17,620
)
Less non-cash warrant liability assumed
    (33,116 )
Net Business Combination and PIPE financing
 
$
107,575
 
Common Stock Issued Following the Consummation of Business Combination
The number of shares of common stock issued immediately following the consummation of the Business Combination:

   
Recapitalization
 
Class A Common Stock of AMCI, outstanding prior to Business Combination
   
9,061,136
 
Less Redemption of AMCI shares
   
(1,606
)
Class B Common Stock of AMCI, outstanding prior to Business Combination
   
5,513,019
 
Shares issued in PIPE
   
6,500,000
 
Business Combination and PIPE financing shares
   
21,072,549
 
Legacy Advent Shares
   
25,033,398
 
Total shares of Common Stock immediately after Business Combination
   
46,105,947
 
UltraCell LLC [Member]  
Business Acquisition [Line Items]  
Assets Acquired and Liabilities Assumed
The assets acquired and liabilities assumed at the date of acquisition were as follows (amounts in thousands):

Current assets
     
Cash and cash equivalents
 
$
78
 
Other current assets
   
658
 
Total current assets
 
$
736
 
Non-current assets
   
9
 
Total assets
 
$
745
 
         
Current liabilities
   
110
 
Non-current liabilities
   
-
 
Total liabilities
 
$
110
 
         
Net assets acquired
 
$
635
 

Goodwill arising on acquisition

Cost of investment
 
$
6,000
 
Net assets value
   
635
 
Consideration to be allocated
 
$
5,365
 
Fair value adjustment - New intangibles
       
     Trade name "UltraCell"
   
406
 
     Patented technology
   
4,328
 
Total intangibles acquired
 
$
4,734
 
Remaining Goodwill
 
$
631
 
SerEnergy and FES [Member]  
Business Acquisition [Line Items]  
Assets Acquired and Liabilities Assumed
The assets acquired and liabilities assumed at the date of acquisition were as follows (amounts in thousands):

Current assets
     
Cash and cash equivalents
 
$
4,367
 
Other current assets
   
10,252
 
Total current assets
 
$
14,619
 
Non-current assets
   
5,388
 
Total assets
 
$
20,007
 
         
Current liabilities
   
5,800
 
Non-current liabilities
   
1,180
 
Total liabilities
 
$
6,980
 
         
Net assets acquired
 
$
13,027
 

Goodwill arising on acquisition

Cost of investment
     
Cash consideration
 
$
22,236
 
Share consideration
   
37,924
 
Total cost of investment
   
60,160
 
Less: Net assets value
   
13,027
 
Original excess purchase price
 
$
47,133
 
Fair value adjustments
       
     Real Property
   
76
 
New intangibles:
       
     Patents
   
16,893
 
     Process know-how (IPR&D)
   
2,612
 
     Order backlog
   
266
 
Total intangibles acquired
 
$
19,771
 
Deferred tax liability arising from the recognition of intangibles and real property valuation
   
(5,452
)
Deferred tax assets on tax losses carried forward
   
3,339
 
Remaining Goodwill
 
$
29,399